Cancers, Di Maio (Aiom): Access to Care Still Affected by Regions and Structures
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.9 Articles
9 Articles
Despite the existence of a national public universalist health service, in Italy we still have a regional declination, so there are steps following publication in the Official Journal, step that would be declaredly speeded up for innovative medicines, as there is an explicit preferential path. But, despite this, even for these drugs sometimes there are bureaucratic difficulties, so there is a risk that, on equal clinical condition, a patient can…
(Adnkronos) "We have to build a shared governance, drug and health in general. Clearly the Aifa-Aiom table of this summer on oncology and oncoematology is very important because we want an Aifa dialogue with scientific societies, with institutions, but also with patient associations. It is clear that regulatory decisions must respond [...]
The 28th National Congress Aiom (Italian Association of Medical Oncology) opens in Rome today, dedicated to the "Equitable Innovation" and the disparities in access to innovative care. A central theme, in the light of the three billion euros of the Fund for innovative medicines that remained unused between 2018 and 2025, denounce the [...]
Rec News | Lontani dal mainstream
notizie.itThe 28th National Congress Aiom (Italian Association of Medical Oncology), dedicated to the "Equitable Innovation" and the disparities in access to innovative care, opens today in Rome. A central theme, in the light of the three billion euros of the Fund for innovative medicines that remained unused between 2018 and 2025, denounces the [...] L'articolo Farmaci, oncologi Aiom: "In 9 years unused 3 billion of the Innovative Fund, care at risk" com…
newsbiella.it
(Adnkronos) - The 28th National Congress Aiom (Italian Association of Medical Oncology) opens in Rome today, dedicated to "Equal Innovation" and disparities in access to innovative care. A central theme, in the light of...
Di Maio (Aiom): "Farmaci," which should be immediately available for all patients, in some cases are not accessible to all. Nisticò (Aifa): "National recognition of a new therapeutic opportunity must result in effective access, without territorial differences" "The post Cancers." In 9 years not spent 3 billion of the Fund for innovative people. Up to 400 days to access new therapies after the "ok" of Aifa. At the start of the XXVIII National Con…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
